oxaliplatin-teva 5mg/ml
pharmachemie b.v. - oxaliplatin - concentrate for solution for infusion - 5mg/ml
oxaliplatin-teva 5mg/ml
pharmachemie b.v. - oxaliplatin - concentrate for solution for infusion - 5mg/ml
fludarabine phosphate 25 mg/ml concentrate for soln for inj
pharmachemie bv - fludarabine phosphate - concentrate for soln for inj - 25 mg/ml - purine analogues
oxaliplatin 5 mg/ml concentrate for soln for inf
pharmachemie bv - oxaliplatin - concentrate for soln for inf - 5 mg/ml - platinum compounds
vorina 25 mg/ml solution for injection
pharmachemie bv - folinic acid - solution for injection - 25 mg/ml - detoxifying agents for antineoplastic treatment
eposin, concentrate for solution for infusion 20mg/ml
pharmachemie b.v. - etoposide, ph.eur. - concentrate for solution for infusion (to dilute). - 20mg/ml - podophyllotoxine derivatives - for the management of: - testicular tumours in combination with other chemotherapeutic agents - small cell lung cancer, in combination with other chemotherapeutic agents - monoblastic leukaemia (aml m5) and acute myelomonoblastic leukaemia (aml m4) when standard therapy has failed (in combination with other chemotherapeutic agents).
paclitaxel-teva
pharmachemie b.v. swensweg 5 - paclitaxel - concentrate for solution for infusion - 6mg/ml
paclitaxel-teva
pharmachemie b.v. swensweg 5 - paclitaxel - concentrate for solution for infusion - 6mg/ml
paclitaxel-teva
pharmachemie b.v. swensweg 5 - paclitaxel - concentrate for solution for infusion - 6mg/ml
paclitaxel-teva
pharmachemie b.v. swensweg 5 - paclitaxel - concentrate for solution for infusion - 6mg/ml